Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat in asymptomatic hyperuricemia for uric acid, metabolic, and anti-atherosclerosis effects
ChiCTR1800017922Phase 4Recruiting
- Sponsor
- Affiliated Huai'an Hospital of Xuzhou Medical University
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of febuxostat in hyperuricemia (2 arms), sponsored by Affiliated Huai'an Hospital of Xuzhou Medical University. Primary endpoints: blood uric acid and blood lipid. Started Sep 2018; status: recruiting.
02
Drugs
febuxostat
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on ChiCTR1800017922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017922.